BlackRock Fund Advisors’s Chembio diagnostics, Inc. CEMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$219K Buy
32,213
+840
+3% +$5.82K ﹤0.01% 3403
2016
Q3
$232K Buy
31,373
+3,540
+13% +$25.5K ﹤0.01% 3402
2016
Q2
$228K Buy
27,833
+22,188
+393% +$173K ﹤0.01% 3407
2016
Q1
$34K Sell
5,645
-109
-2% -$563 ﹤0.01% 3855
2015
Q4
$31K Buy
5,754
+1,093
+23% +$5.48K ﹤0.01% 3931
2015
Q3
$19K Sell
4,661
-126
-3% -$570 ﹤0.01% 3889
2015
Q2
$24K Buy
4,787
+582
+14% +$2.69K ﹤0.01% 3850
2015
Q1
$17K Sell
4,205
-288
-6% -$1.13K ﹤0.01% 3737
2014
Q4
$18K Buy
4,493
+324
+8% +$1.34K ﹤0.01% 3711
2014
Q3
$16K Sell
4,169
-306
-7% -$1.07K ﹤0.01% 3775
2014
Q2
$15K Buy
4,475
+128
+3% +$411 ﹤0.01% 3733
2014
Q1
$15K Buy
4,347
+528
+14% +$1.85K ﹤0.01% 3714
2013
Q4
$13K Buy
3,819
+160
+4% +$565 ﹤0.01% 3724
2013
Q3
$13K Buy
3,659
+288
+9% +$1.22K ﹤0.01% 3698
2013
Q2
$17K Buy
+3,371
New +$15.6K ﹤0.01% 3673

Other funds holding CEMI

BlackRock Fund Advisors's CEMI Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Chembio diagnostics, Inc. (CEMI) stake by 2.7% in Q4 2016, buying an estimated $5.82K and bringing the position to 32,213 shares worth $219K. The position accounts for ﹤0.01% of the portfolio, ranked #3403.

BlackRock Fund Advisors first reported a position in CEMI in Q2 2013 and has held it in 15 quarters since. The position peaked at $232K in Q3 2016. 26 funds tracked by Wall St. Rank hold CEMI as of Q4 2016.

  • BlackRock Fund Advisors held 32,213 shares of Chembio diagnostics, Inc. worth $219K as of Q4 2016.
  • BlackRock Fund Advisors bought 840 Chembio diagnostics, Inc. shares in Q4 2016, an estimated $5.82K.
  • Chembio diagnostics, Inc. made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3403 holding.
  • BlackRock Fund Advisors first reported a position in Chembio diagnostics, Inc. in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Chembio diagnostics, Inc. position peaked at $232K in Q3 2016.
  • 26 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.